Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections

Journal of Child Neurology

Volumn 25, Issue 6, 2010, Pages 694-700

  Keren Capelovitch, Tal ^a   Jarus, Tal ^b   Fattal Valevski, Aviva ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Botulinum toxin A; Cerebral palsy; Lower extremity; Occupational performance; Upper extremity

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CANADIAN OCCUPATIONAL PERFORMANCE MEASURE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HUMAN; MALE; MOTOR PERFORMANCE; MUSCLE FUNCTION; OPEN STUDY; PATIENT ASSESSMENT; PEDIATRIC EVALUATION OF DISABILITY INVENTORY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF UPPER EXTREMITY SKILLS TEST; SATISFACTION; SCHOOL CHILD; SPASTICITY; TASK PERFORMANCE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ANALYSIS OF VARIANCE; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CANADA; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LOWER EXTREMITY; MALE; MOTOR ACTIVITY; MOTOR SKILLS; PATIENT SATISFACTION; PSYCHOMOTOR PERFORMANCE; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 77952908735     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809344621     Document Type: Article

References (29)

1. Law M, Polatajko H, Baptiste S, Townsend E. Core concepts of occupational therapy. In: Townsend E, ed. Enabling Occupation: An Occupational Therapy Perspective. Ottawa, Canada: Canadian Association of Occupational Therapists ; 1997: 29-56.
2. Law M. Participation in the occupations of everyday life. Am J Occup Ther. 2002 ; 56 (6). 640-649.
3. Dunne JW, Heye N., Dunne SL Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry. 1995 ; 58 (2). 232-235.
4. Boyd RN, Morris ME, Graham HK Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol. 2001 ; 8 (suppl 5). 150-166.
5. Albanese A. The current status and use of botulinum toxins. Eur J Neurol. 2001 ; 8 (suppl): s3 - s7.
6. Slawek J., Klimont L. Functional improvement in cerebral palsy patients treated with botulinum toxin A injections-preliminary results. Eur J Neurol. 2003 ; 10 (3). 313-317.
7. Fargala MA, O'neil ME, Russo KJ, Dimas HM Impairment, disability and satisfaction outcomes after lower extremity botulinum toxin A injection for children with cerebral palsy. Pediatr Phys Ther. 2002 ; 14 (3). 132-144.
8. Fehlings D., Rang M., Glazier J., Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr. 2000 ; 137 (3). 331-337.
9. Wallen MA, O'Flaherty SJ, Waugh MA Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial. Arch Phys Med Rehabil. 2004 ; 85 (2). 192-200.
10. Hurvitz EA, Conti GE, Brown SH Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Arch Phys Med Rehabil. 2003 ; 84 (3). 444-454.
11. Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Am J Phys Med Rehabil. 2003 ; 82 (4). 284-289.
12. Palisano JR, Cameron D., Rosenbaum PL, Walter SD, Russell D. Stability of the Gross Motor Function Classification System. Dev Med Child Neurol. 2006 ; 48 (6). 424-428.
13. American Occupational Therapy Association. Occupational therapy practice framework: Domain and process. Am J Occup Ther. 2002 ; 56 (6). 609-639.
14. DeMatteo C., Law M., Russell D., Pollock N., Rosenbaum P., Walter S. The reliability and validity of the quality of upper extremity skill test. Phys Occup Ther Pediatr. 1993 ; 13 (2). 1-18.
15. Law M., Polatajko H., Pollock N., McColl MA, Carswell A., Baptiste S. Pilot testing of the Canadian Occupational Performance Measure: Clinical and measurement Issues. Can J Occup Ther. 1994 ; 61 (4). 191-197.
16. Nichols DS, Case-Smith J. Reliability and Validity of the Pediatric Evaluation of Disability Inventory. Pediatr Phys Ther. 1996 ; 8 (1). 15-24.
17. Fda. Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B). http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm070366.htm
18. Mayston MJ People with cerebral palsy: effects of and perspective for therapy. Neural Plast. 2001 ; 8 (1-2). 51-69.
19. Levin MF, Sveistrup H. Postural control for reaching and hand skills. In: Eliasson AC, Burtner PA, eds. Improving Hand Function in Children With Cerebral palsy: Theory, Evidence And Intervention. London, UK: Mac Keith Press; 2008: 109-124.
20. McClenaghan BA, Thomas L., Milner M. Effects of seat-surface inclination on postural stability and function of upper extremities of children with cerebral palsy. Dev Med Child Neurol. 1992 ; 34 (1). 40-48.
21. Lin JP The assessment and management of hypertonus in cerebral palsy: a physiological atlas ('road map'). In: Scrutton D, Damiano D, Maystone M, eds. Management of the Motor Disorders of Children With Cerebral Palsy. Clin Develop Med No 161, London, UK: Mac Keith press ; 2004: 85-104.
22. Howle JM Neuro-Developmental Treatment Approach Theoretical Foundations and Principles of Clinical Practice. (2 nd ed). Laguna Beach, CA: Neuro-Developmental Treatment Association.
23. Palisano JR, Snider LM, Orlin MN Recent advances in physical and occupational therapy for children with cerebral palsy. Semin Neurol. 2004 ; 11 (1). 66-77.
24. Beckung E., Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol. 2002 ; 44 (5). 309-316.
25. Boyd RN, Hays RM Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol. 2001 ; 8 (suppl 5). 1-20.
26. Carr LJ, Cosgrover AP, Gringras P., Neville BGR, on behalf of the UK Botulinum Toxin and Cerebral Palsy Working Party. Position paper on the use of botulinum toxin in cerebral palsy. Arch Dis Child. 1998 ; 79: 271-273.
27. Sheean GL Botulinum treatment of spasticity: why is it so difficult to show a functional benefit ? Curr Opin Neurol. 2001 ; 14 (6). 771-776.
28. Law M., Cooper B., Strong S., et al. Person-environment-occupation model: A transactive approach to occupational performance. Can J Occup Ther. 1996 ; 63 (1). 9-23.
29. Fattal-Valevski A., Domenievitz D., Giladi N., Wientroub S., Hayek S. Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study. J Child Orthop. 2008 ; 2 (1). 29-35.